BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bachtarzi H, Stevenson M, Šubr V, Ulbrich K, Seymour LW, Fisher KD. Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins. Journal of Controlled Release 2011;150:196-203. [DOI: 10.1016/j.jconrel.2010.10.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Reschke M, Piotrowski-Daspit AS, Pober JS, Saltzman WM. Nucleic Acid Delivery to the Vascular Endothelium. Mol Pharm 2022. [PMID: 36251765 DOI: 10.1021/acs.molpharmaceut.2c00653] [Reference Citation Analysis]
2 Barry MA, Rubin JD, Lu SC. Retargeting adenoviruses for therapeutic applications and vaccines. FEBS Lett 2020;594:1918-46. [PMID: 31944286 DOI: 10.1002/1873-3468.13731] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
3 Chantarasrivong C, Higuchi Y, Tsuda M, Yamane Y, Hashida M, Konishi M, Komura N, Ando H, Yamashita F. Sialyl LewisX mimic-decorated liposomes for anti-angiogenic everolimus delivery to E-selectin expressing endothelial cells. RSC Adv 2019;9:20518-27. [DOI: 10.1039/c9ra01943j] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wen AM, Steinmetz NF. Design of virus-based nanomaterials for medicine, biotechnology, and energy. Chem Soc Rev 2016;45:4074-126. [PMID: 27152673 DOI: 10.1039/c5cs00287g] [Cited by in Crossref: 251] [Cited by in F6Publishing: 259] [Article Influence: 62.8] [Reference Citation Analysis]
5 Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Du Y, Prior JL, Leib DJ, Chauchereau A, Sehn JK, Curiel DT, Arbeit JM. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector. Oncotarget 2017;8:12272-89. [PMID: 28103576 DOI: 10.18632/oncotarget.14699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wodicka JR, Chambers AM, Sangha GS, Goergen CJ, Panitch A. Development of a Glycosaminoglycan Derived, Selectin Targeting Anti-Adhesive Coating to Treat Endothelial Cell Dysfunction. Pharmaceuticals (Basel) 2017;10:E36. [PMID: 28353658 DOI: 10.3390/ph10020036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
7 Mužíková G, Pola R, Laga R, Pechar M. Biodegradable Multiblock Polymers Based on N -(2-Hydroxypropyl)methacrylamide Designed as Drug Carriers for Tumor-Targeted Delivery. Macromol Chem Phys 2016;217:1690-703. [DOI: 10.1002/macp.201600097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 Laakkonen JP, Ylä-herttuala S. Animal Models of Gene Therapy for Cardiovascular Disease. Adenoviral Vectors for Gene Therapy 2016. [DOI: 10.1016/b978-0-12-800276-6.00028-0] [Reference Citation Analysis]
9 Tedcastle A, Illingworth S, Brown A, Seymour LW, Fisher KD. Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth. Mol Ther 2016;24:796-804. [PMID: 26708004 DOI: 10.1038/mt.2015.233] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
10 Roy D, Power A, Bourgeois-daigneault M, Falls T, Ferreira L, Stern A, Tanese de Souza C, Mccart J, Stojdl D, Lichty B, Atkins H, Auer R, Bell J, Le Boeuf F. Programmable insect cell carriers for systemic delivery of integrated cancer biotherapy. Journal of Controlled Release 2015;220:210-21. [DOI: 10.1016/j.jconrel.2015.10.030] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
11 Puig-saus C, Rojas LA, Laborda E, Figueras A, Alba R, Fillat C, Alemany R. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther 2014;21:767-74. [DOI: 10.1038/gt.2014.52] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
12 Hingorani P, Sampson V, Lettieri C, Kolb EA. Oncolytic Viruses for Potential Osteosarcoma Therapy. Advances in Experimental Medicine and Biology 2014. [DOI: 10.1007/978-3-319-04843-7_14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Lu ZH, Kaliberov S, Sohn RE, Kaliberova L, Curiel DT, Arbeit JM. Transcriptional targeting of primary and metastatic tumor neovasculature by an adenoviral type 5 roundabout4 vector in mice. PLoS One 2013;8:e83933. [PMID: 24376772 DOI: 10.1371/journal.pone.0083933] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kaliberov SA, Kaliberova LN, Hong Lu Z, Preuss MA, Barnes JA, Stockard CR, Grizzle WE, Arbeit JM, Curiel DT. Retargeting of gene expression using endothelium specific hexon modified adenoviral vector. Virology 2013;447:312-25. [PMID: 24210128 DOI: 10.1016/j.virol.2013.09.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
15 Roy DG, Bell JC. Cell carriers for oncolytic viruses: current challenges and future directions.Oncolytic Virother. 2013;2:47-56. [PMID: 27512657 DOI: 10.2147/OV.S36623] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
16 Lee HJ, Namgung R, Kim WJ, Kim JI, Park I. Targeted delivery of microRNA-145 to metastatic breast cancer by peptide conjugated branched PEI gene carrier. Macromol Res 2013;21:1201-9. [DOI: 10.1007/s13233-013-1161-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
17 Cho SK, Kwon YJ. Synthetically engineered viruses: Can synthetic chemistry tame the nature? Current Opinion in Solid State and Materials Science 2012;16:276-86. [DOI: 10.1016/j.cossms.2012.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Carlisle R, Seymour LW, Coussios CC. Targeting of liposomes via PSGL1 for enhanced tumor accumulation. Pharm Res 2013;30:352-61. [PMID: 22992830 DOI: 10.1007/s11095-012-0875-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
19 Shen M, Huang Y, Han L, Qin J, Fang X, Wang J, Yang VC. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. Journal of Controlled Release 2012;161:884-92. [DOI: 10.1016/j.jconrel.2012.05.013] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 8.0] [Reference Citation Analysis]
20 Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy. Nat Biotechnol. 2012;30:658-670. [PMID: 22781695 DOI: 10.1038/nbt.2287] [Cited by in Crossref: 906] [Cited by in F6Publishing: 964] [Article Influence: 90.6] [Reference Citation Analysis]
21 Tedcastle A, Cawood R, Di Y, Fisher KD, Seymour LW. Virotherapy – cancer targeted pharmacology. Drug Discovery Today 2012;17:215-20. [DOI: 10.1016/j.drudis.2011.12.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
22 Laga R, Carlisle R, Tangney M, Ulbrich K, Seymour LW. Polymer coatings for delivery of nucleic acid therapeutics. J Control Release. 2012;161:537-553. [PMID: 22366547 DOI: 10.1016/j.jconrel.2012.02.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
23 de Gruijl TD, van de Ven R. Chapter six--Adenovirus-based immunotherapy of cancer: promises to keep. Adv Cancer Res 2012;115:147-220. [PMID: 23021245 DOI: 10.1016/B978-0-12-398342-8.00006-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
24 Verheije MH, Rottier PJ. Retargeting of viruses to generate oncolytic agents. Adv Virol 2012;2012:798526. [PMID: 22312365 DOI: 10.1155/2012/798526] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
25 Vighi E, Leo E, Montanari M, Mucci A, Hanuskova M, Iannuccelli V. Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier. Therapeutic Delivery 2011;2:1419-35. [DOI: 10.4155/tde.11.118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
26 Jubeli E, Moine L, Vergnaud-Gauduchon J, Barratt G. E-selectin as a target for drug delivery and molecular imaging. J Control Release. 2012;158:194-206. [PMID: 21983284 DOI: 10.1016/j.jconrel.2011.09.084] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
27 Park K. Selective endothelial targeting of stealthed adenovirus. J Control Release 2011;150:127. [PMID: 21354225 DOI: 10.1016/j.jconrel.2011.02.019] [Reference Citation Analysis]